Company Newbury Pharmaceuticals AB

Equities

NEWBRY

SE0015244884

Drug Retailers

Delayed Nasdaq Stockholm 17:00:00 20/06/2024 BST 5-day change 1st Jan Change
3.46 SEK +8.81% Intraday chart for Newbury Pharmaceuticals AB +8.12% +12.70%

Business Summary

Newbury Pharmaceuticals AB is a Sweden-based pharmaceutical company for specialty prescription drugs. The Company’s existing portfolio is focused on the Scandinavian market and consists of pharmaceuticals from several therapeutic areas with oncology, rare diseases and neurology.

Number of employees: 5

Managers

Managers TitleAgeSince
Chief Executive Officer 53 31/12/20
Director of Finance/CFO 37 31/12/20
Director/Board Member - 31/07/22
Sales & Marketing 51 31/12/20

Members of the board

Members of the board TitleAgeSince
Founder 50 31/12/19
Director/Board Member 50 31/12/19
Director/Board Member 48 31/12/19
Director/Board Member 38 31/12/20
Director/Board Member - 31/07/22

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 19,521,154 9,005,041 ( 46.13 %) 0 46.13 %

Shareholders

NameEquities%Valuation
9,905,924 40.83 % 3 M kr
Sumar Pharma Ltd.
12.73 %
3,087,308 12.73 % 892 386 kr
Pension Futur
4.164 %
1,010,050 4.164 % 291 955 kr
531,590 2.191 % 153 656 kr
393,082 1.620 % 113 620 kr
275,000 1.134 % 79 489 kr
Anil Okay
1.119 %
271,500 1.119 % 78 477 kr
Nordnet Pension Insurance
1.022 %
247,846 1.022 % 71 640 kr
Hexiron AB
0.9513 %
230,770 0.9513 % 66 704 kr
Gerhard Dal
0.9471 %
229,743 0.9471 % 66 407 kr

Company contact information

Newbury Pharmaceuticals AB

Medicon Village Scheeletorget 1

223 81, Lund

+46 46 12 11 20

http://www.newburypharma.com
address Newbury Pharmaceuticals AB(NEWBRY)
  1. Stock Market
  2. Equities
  3. NEWBRY Stock
  4. Company Newbury Pharmaceuticals AB